Connect Biopharma Holdings Ltd ADR (CNTB)

Connect Biopharma Holdings Ltd ADR Aktie (CNTB) Neueste Nachrichten

Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma

GlobeNewswire Inc.

Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire Inc.

Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors

GlobeNewswire Inc.

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

Zacks Investment Research

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Benzinga

Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma

GlobeNewswire Inc.

Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023

GlobeNewswire Inc.

Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Benzinga

Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

GlobeNewswire Inc.

Connect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis

GlobeNewswire Inc.

Connect Biopharma to Announce Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis on November 21, 2023

GlobeNewswire Inc.